Implantable Drug Delivery Devices

Implantable Drug Delivery Devices

Global Implantable Drug Delivery Devices Market to Reach $37 Billion by 2030
The global market for Implantable Drug Delivery Devices estimated at US$24.4 Billion in the year 2023, is expected to reach US$37 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. Contraceptive Implants, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$9 Billion by the end of the analysis period. Growth in the Spinal Implants segment is estimated at 5.7% CAGR for the next 7-year period.

The U.S. Market is Estimated at $7.4 Billion, While China is Forecast to Grow at 5.7% CAGR
The Implantable Drug Delivery Devices market in the U.S. is estimated at US$7.4 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.4 Billion by the year 2030 trailing a CAGR of 5.7% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.8% and 4.9% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 5% CAGR.

What to Expect from the Global Economy in 2024
Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 46 Featured) -
  • Abbott Laboratories
  • Allergan PLC
  • Bausch and Lomb, Inc.
  • Bayer AG
  • Boston Scientific Corporation
  • Medtronic PLC
  • Merck & Co., Inc.
  • Teleflex, Inc.
  • Varian Medical Systems, Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Implantable Drug Delivery Devices - Global Key Competitors Percentage Market Share in 2024 (E)
Global Economic Update
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Implantable Drug Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Implantable Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Contraceptive Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Contraceptive Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Contraceptive Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Spinal Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Spinal Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Spinal Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Brachytherapy Seeds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Brachytherapy Seeds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Brachytherapy Seeds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for Drug Eluting Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Bio-absorbable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for Bio-absorbable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 18: World 16-Year Perspective for Bio-absorbable Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Intraocular Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 20: World Historic Review for Intraocular Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 21: World 16-Year Perspective for Intraocular Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 23: World Historic Review for Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 24: World 16-Year Perspective for Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 25: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 26: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 27: World 16-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 28: World Recent Past, Current & Future Analysis for Biodegradable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 29: World Historic Review for Biodegradable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 30: World 16-Year Perspective for Biodegradable by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 31: World Recent Past, Current & Future Analysis for Non-biodegradable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 32: World Historic Review for Non-biodegradable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 33: World 16-Year Perspective for Non-biodegradable by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 34: World Recent Past, Current & Future Analysis for Diffusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 35: World Historic Review for Diffusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 36: World 16-Year Perspective for Diffusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 37: World Recent Past, Current & Future Analysis for Osmotic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 38: World Historic Review for Osmotic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 39: World 16-Year Perspective for Osmotic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 40: World Recent Past, Current & Future Analysis for Magnetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 41: World Historic Review for Magnetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 42: World 16-Year Perspective for Magnetic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 43: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 44: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 45: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 46: World Recent Past, Current & Future Analysis for Contraception by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 47: World Historic Review for Contraception by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 48: World 16-Year Perspective for Contraception by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 49: World Recent Past, Current & Future Analysis for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 50: World Historic Review for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 51: World 16-Year Perspective for Ophthalmology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 52: World Recent Past, Current & Future Analysis for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 53: World Historic Review for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 54: World 16-Year Perspective for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 55: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 56: World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 57: World 16-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 58: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 59: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 60: World 16-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 61: World Recent Past, Current & Future Analysis for Autoimmune Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 62: World Historic Review for Autoimmune Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 63: World 16-Year Perspective for Autoimmune Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 64: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 65: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 66: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 67: World Implantable Drug Delivery Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 68: USA Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: USA Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: USA 16-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2014, 2024 & 2030
TABLE 71: USA Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: USA Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: USA 16-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2014, 2024 & 2030
TABLE 74: USA Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: USA Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: USA 16-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2014, 2024 & 2030
TABLE 77: USA Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: USA Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: USA 16-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2014, 2024 & 2030
CANADA
TABLE 80: Canada Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: Canada Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: Canada 16-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2014, 2024 & 2030
TABLE 83: Canada Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: Canada Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: Canada 16-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2014, 2024 & 2030
TABLE 86: Canada Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: Canada Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: Canada 16-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2014, 2024 & 2030
TABLE 89: Canada Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: Canada Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: Canada 16-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2014, 2024 & 2030
JAPAN
Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 92: Japan Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: Japan Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: Japan 16-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2014, 2024 & 2030
TABLE 95: Japan Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Japan Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Japan 16-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2014, 2024 & 2030
TABLE 98: Japan Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Japan Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Japan 16-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2014, 2024 & 2030
TABLE 101: Japan Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: Japan Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Japan 16-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2014, 2024 & 2030
CHINA
Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 104: China Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: China Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: China 16-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2014, 2024 & 2030
TABLE 107: China Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: China Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: China 16-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2014, 2024 & 2030
TABLE 110: China Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 111: China Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 112: China 16-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2014, 2024 & 2030
TABLE 113: China Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 114: China Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 115: China 16-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2014, 2024 & 2030
EUROPE
Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 116: Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 117: Europe Historic Review for Implantable Drug Delivery Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 118: Europe 16-Year Perspective for Implantable Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 119: Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 120: Europe Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 121: Europe 16-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2014, 2024 & 2030
TABLE 122: Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 123: Europe Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 124: Europe 16-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2014, 2024 & 2030
TABLE 125: Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 126: Europe Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 127: Europe 16-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2014, 2024 & 2030
TABLE 128: Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 129: Europe Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 130: Europe 16-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2014, 2024 & 2030
FRANCE
Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 131: France Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 132: France Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 133: France 16-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2014, 2024 & 2030
TABLE 134: France Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 135: France Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 136: France 16-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2014, 2024 & 2030
TABLE 137: France Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 138: France Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 139: France 16-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2014, 2024 & 2030
TABLE 140: France Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 141: France Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 142: France 16-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2014, 2024 & 2030
GERMANY
Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 143: Germany Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 144: Germany Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 145: Germany 16-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2014, 2024 & 2030
TABLE 146: Germany Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 147: Germany Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 148: Germany 16-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2014, 2024 & 2030
TABLE 149: Germany Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 150: Germany Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 151: Germany 16-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2014, 2024 & 2030
TABLE 152: Germany Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 153: Germany Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 154: Germany 16-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2014, 2024 & 2030
ITALY
TABLE 155: Italy Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 156: Italy Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 157: Italy 16-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2014, 2024 & 2030
TABLE 158: Italy Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 159: Italy Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 160: Italy 16-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2014, 2024 & 2030
TABLE 161: Italy Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 162: Italy Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 163: Italy 16-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2014, 2024 & 2030
TABLE 164: Italy Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 165: Italy Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 166: Italy 16-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2014, 2024 & 2030
UNITED KINGDOM
Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 167: UK Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 168: UK Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 169: UK 16-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2014, 2024 & 2030
TABLE 170: UK Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 171: UK Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 172: UK 16-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2014, 2024 & 2030
TABLE 173: UK Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 174: UK Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 175: UK 16-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2014, 2024 & 2030
TABLE 176: UK Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 177: UK Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 178: UK 16-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 180: Rest of Europe Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 181: Rest of Europe 16-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2014, 2024 & 2030
TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 183: Rest of Europe Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 184: Rest of Europe 16-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2014, 2024 & 2030
TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 186: Rest of Europe Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 187: Rest of Europe 16-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2014, 2024 & 2030
TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 189: Rest of Europe Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 190: Rest of Europe 16-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Implantable Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 192: Asia-Pacific Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 193: Asia-Pacific 16-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2014, 2024 & 2030
TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 195: Asia-Pacific Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 196: Asia-Pacific 16-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2014, 2024 & 2030
TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 198: Asia-Pacific Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 199: Asia-Pacific 16-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2014, 2024 & 2030
TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 201: Asia-Pacific Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 202: Asia-Pacific 16-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2014, 2024 & 2030
REST OF WORLD
TABLE 203: Rest of World Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 204: Rest of World Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 205: Rest of World 16-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2014, 2024 & 2030
TABLE 206: Rest of World Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 207: Rest of World Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 208: Rest of World 16-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2014, 2024 & 2030
TABLE 209: Rest of World Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 210: Rest of World Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 211: Rest of World 16-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2014, 2024 & 2030
TABLE 212: Rest of World Recent Past, Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 213: Rest of World Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 214: Rest of World 16-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings